A Descriptive Study of the Feasibility of a Public Cord Blood Bank to Facilitate Allogenic Unrelated Donor Umbilical Cord Blood Transplant and Research
Investigation of [Condition] Treatment Efficacy
Not Recruiting
18 years - 100 years
Female
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Feasibility Study
Age:
18 years - 100 years
Gender: Female
Who can participate: Participants aged 18 to 65 with a confirmed diagnosis of [Condition] are eligible. Key inclusion criteria include [specific criteria], while exclusion criteria include [specific criteria].
Study details: Participants will receive the investigational treatment or placebo once daily for 12 weeks. A placebo is an inactive substance designed to mimic the investigational treatment without containing active ingredients. Participants will undergo regular assessments to monitor their response to the treatment.
Updated on
19 Feb 2024.
Study ID: 101002129 (06-072)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
